ES2043117T3 - Composicon que contiene fosfolipidos, un proceso para su preparacion, y su uso como excipiente para substancias farmaceuticas. - Google Patents

Composicon que contiene fosfolipidos, un proceso para su preparacion, y su uso como excipiente para substancias farmaceuticas.

Info

Publication number
ES2043117T3
ES2043117T3 ES89908999T ES89908999T ES2043117T3 ES 2043117 T3 ES2043117 T3 ES 2043117T3 ES 89908999 T ES89908999 T ES 89908999T ES 89908999 T ES89908999 T ES 89908999T ES 2043117 T3 ES2043117 T3 ES 2043117T3
Authority
ES
Spain
Prior art keywords
excipient
preparation
composition containing
pharmaceutical substances
containing phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89908999T
Other languages
English (en)
Spanish (es)
Inventor
Gajdos
Mentzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Application granted granted Critical
Publication of ES2043117T3 publication Critical patent/ES2043117T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES89908999T 1988-08-09 1989-08-01 Composicon que contiene fosfolipidos, un proceso para su preparacion, y su uso como excipiente para substancias farmaceuticas. Expired - Lifetime ES2043117T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3826946A DE3826946C1 (cg-RX-API-DMAC7.html) 1988-08-09 1988-08-09

Publications (1)

Publication Number Publication Date
ES2043117T3 true ES2043117T3 (es) 1993-12-16

Family

ID=6360482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89908999T Expired - Lifetime ES2043117T3 (es) 1988-08-09 1989-08-01 Composicon que contiene fosfolipidos, un proceso para su preparacion, y su uso como excipiente para substancias farmaceuticas.

Country Status (10)

Country Link
US (1) US5114928A (cg-RX-API-DMAC7.html)
EP (2) EP0428582B1 (cg-RX-API-DMAC7.html)
JP (1) JPH02504397A (cg-RX-API-DMAC7.html)
KR (1) KR930003882B1 (cg-RX-API-DMAC7.html)
CN (1) CN1037149C (cg-RX-API-DMAC7.html)
CA (1) CA1336957C (cg-RX-API-DMAC7.html)
DE (2) DE3826946C1 (cg-RX-API-DMAC7.html)
ES (1) ES2043117T3 (cg-RX-API-DMAC7.html)
GR (1) GR3004892T3 (cg-RX-API-DMAC7.html)
WO (1) WO1990001269A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US4971798A (en) * 1989-11-30 1990-11-20 Miles Inc. Hard confections containing hydrogenated isomaltulose and medicinally active ingredient
DK0616799T3 (da) * 1993-03-24 2000-09-18 Collaborative Lab Inc Kosmetisk applikationssystem for salicylsyre og fremgangsmåde til fremstilling heraf
EP0650669B1 (en) * 1993-10-29 2002-01-09 Dsm N.V. Baking improver compositions
DE19536394A1 (de) * 1995-09-29 1997-04-03 Basf Ag Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
DE19629167C2 (de) * 1996-07-19 2000-05-04 Einhorn Apotheke Dr Guenther H Feste orale, antikariogene Zusammensetzung in Form einer Lutschtablette zum Reinigen der Mundhöhle und Zähne
US6312703B1 (en) * 1998-02-06 2001-11-06 Lecigel, Llc Compressed lecithin preparations
DE19818842C1 (de) * 1998-04-28 2000-01-05 Suedzucker Ag Erkältungsmittel
HU226710B1 (en) * 1998-05-27 2009-07-28 Euro Celtique Sa Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
GB9828013D0 (en) * 1998-12-18 1999-02-10 Lovesgrove Res Ltd Specific phospholipid-lipid mixtures for inclusion in animal feed
ES2274372T3 (es) 1999-05-27 2007-05-16 Euro-Celtique S.A. Uso de antisepticos en la fabricacion de un preparado farmaceutico para la prevencion o el tratamiento de inflamaciones en el interior del cuerpo humano.
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
WO2001000178A1 (fr) * 1999-06-29 2001-01-04 Takeda Chemical Industries, Ltd. Comprimes se desintegrant rapidement dans la bouche
DE10340741A1 (de) * 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Formulierung auf Phospholipidbasis
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
US20070224265A1 (en) * 2004-04-14 2007-09-27 Takahiro Hara Tablet Comprising Branched Chain Amino Acid and Method for Producing the Same
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
EP1893038A1 (en) * 2005-05-17 2008-03-05 Cargill, Incorporated Granular lecithins, granular lysolecithins, process for their production and compositions containing them
US20140072617A1 (en) * 2007-09-26 2014-03-13 Lvmh Recherche Method for preventing or slowing down the appearance of the effects of skin ageing using a tocopheryl phosphate in liposomes
RU2376011C1 (ru) * 2008-05-19 2009-12-20 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для ухода за областью периферических суставов и позвоночника
AR080293A1 (es) * 2010-03-12 2012-03-28 Danisco Proceso de refinamiento de un aceite vegetal
JP5901617B2 (ja) * 2010-05-14 2016-04-13 アーチャー−ダニエルズ−ミッドランド カンパニー オルガノゲルを含む食品組成物
US10117885B2 (en) 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
US11253531B2 (en) 2011-08-11 2022-02-22 Nutritional Therapeutics, Inc. Lipid supplements for reducing nerve action potentials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2057695A (en) * 1933-12-13 1936-10-20 American Lecithin Co Method for the production of vegetable phosphatide preparations
US2447726A (en) * 1945-09-21 1948-08-24 Wilber J Allingham Lecithin composition
US2430553A (en) * 1946-11-02 1947-11-11 Frank E Bigelow Lecithinated sugar
US2708631A (en) * 1952-10-21 1955-05-17 Sadie Neiman Lecithin composition and method of producing the same
US3012888A (en) * 1959-04-13 1961-12-12 Central Soya Co Method for preparing a granular oilfree phosphatide product
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form

Also Published As

Publication number Publication date
KR930003882B1 (ko) 1993-05-15
DE68901771T2 (de) 1992-12-17
DE3826946C1 (cg-RX-API-DMAC7.html) 1990-03-15
JPH02504397A (ja) 1990-12-13
CN1037149C (zh) 1998-01-28
EP0428582A1 (en) 1991-05-29
CA1336957C (en) 1995-09-12
WO1990001269A1 (en) 1990-02-22
US5114928A (en) 1992-05-19
KR900701174A (ko) 1990-12-01
CN1040144A (zh) 1990-03-07
DE68901771D1 (de) 1992-07-16
EP0354442A1 (en) 1990-02-14
EP0428582B1 (en) 1992-06-10
GR3004892T3 (cg-RX-API-DMAC7.html) 1993-04-28
JPH0571596B2 (cg-RX-API-DMAC7.html) 1993-10-07

Similar Documents

Publication Publication Date Title
ES2043117T3 (es) Composicon que contiene fosfolipidos, un proceso para su preparacion, y su uso como excipiente para substancias farmaceuticas.
ES2032755T3 (es) Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral.
MY8600471A (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa and method for administration thereof
IL60326A0 (en) Pharmaceutical compositions for parenteral administration of fatsolbule active substances
SE8103843L (sv) Farmaceutisk mixtur
ZA858108B (en) Stabilized composition containing inositoltriphosphate
IL76700A0 (en) Pharmaceutical compositions containing liposomes of synthetic lipids and their manufacture
PT90120A (pt) Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
ES2031904T3 (es) Procedimiento para producir una composicion farmaceutica que contiene ibuprofeno y hidroxido de aluminio.
SE8505736D0 (sv) Preparations, mainly confectionery preparations reducing the incidence of dental caries and methods of preparing said preparations
PT76919A (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
DK524884A (da) Farmaceutiske praeparater indeholdende phosphatidylserin og fremgangsmaade til fremstilling deraf
CA2117769A1 (en) Liposome composition
JPS6429314A (en) Medicine dosage
ES2001099A6 (es) Procedimiento para la preparacion de una composicion farmaceutica a base de fosfolipidos.
PT81429A (en) Process for preparing solid drug formulations and stable suspensions containing 4-hydroxy- or 4-aciloxi-4-androstene-3,17-diones
GB2065133B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB2065135B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB2065134B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
MY101916A (en) Etoposide oral dosage form.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
PT86061A (en) Process for the preparation of analgesic pharmaceutical compositions containing a synergic mixture of ibuprofen with tizanidine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 428582

Country of ref document: ES